Skip to main content

Kyber Data Science Announces $10 Million Series A Financing Round

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) — Kyber Data Science LLC (“Kyber”), a subsidiary of Cowen Inc. (NASDAQ:COWN) (“Cowen”), today announced a $10 million Series A financing round led by Cowen and Ian McKinnon, founder of Sandia Holdings LLC (“Sandia”). Mr. McKinnon has joined Kyber’s board of directors, effective upon closing of the investment.
Kyber is focused on developing and selling unique and proprietary datasets across a variety of sectors to institutional investors and corporations.  Most recently, Kyber unveiled a nationally-representative health care claims and electronic medical records data product for the institutional investor that enables timely and accurate analyses across health care subsectors including drug, medical device, diagnostics, and facilities companies. Transaction-level data allow customers to develop a large number of key performance indicators, and drive granular insights into the intricacies of product revenue and disease dynamics.“At Cowen, we are constantly striving to help clients outperform and to build systems and services that are deeply entrenched within the DNA of the sectors that we serve,” said Jeffrey M. Solomon, Chair and Chief Executive Officer of Cowen.  “Kyber is uniquely positioned to expertly manage big data sets and to provide actionable insights to the financial community.  We have been extremely pleased with the establishment of the business and are thrilled to be partnering with Sandia on the next leg of growth.”“Kyber was established on the belief that data is a tool for alpha generation versus data as a strategy unto itself,” said Robert Fagin, Kyber’s Executive Chair.  “As we have continued to grow our product sets, we are extremely pleased to elevate our operation through outside capital and the participation of Ian McKinnon as a director.  Ian has tremendous experience growing health care and data-focused companies and we look forward to his contributions.”Located in Greenwich, Connecticut, Sandia is the primary investment vehicle for the McKinnon family and related entities. Prior to starting Sandia, Ian spent nearly twenty years at Ziff Brothers Investments (“ZBI”), from which he retired as a Managing Partner. Prior to joining ZBI, Ian was a consultant with Bain & Company and an investment banking analyst with Merrill Lynch & Co.“I have had a passion for health care from the time I walked rounds in the hospital with my grandfather, who was a surgeon.  Life sciences has always been a core focus of my investment activities, so it only seems fitting to partner with Cowen in helping to create Kyber, as Cowen now boasts one of the leading health care platforms on the Street,” said Ian McKinnon, founding partner of Sandia.About Cowen Inc.Cowen is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the Company is headquartered in New York and has offices worldwide. Learn more at Cowen.com.Media Contacts:

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.